In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $5.18 in the prior trading day, Protara Therapeutics Inc (NASDAQ: TARA) closed at $5.27, up 1.74%. In other words, the price has increased by $1.74 from its previous closing price. On the day, 0.97 million shares were traded. TARA stock price reached its highest trading level at $5.4 during the session, while it also had its lowest trading level at $5.11.
Ratios:
Our goal is to gain a better understanding of TARA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.69 and its Current Ratio is at 13.69. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In the most recent recommendation for this company, Scotiabank on April 16, 2025, initiated with a Sector Outperform rating and assigned the stock a target price of $12.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 14 ’25 when Levy Richard S bought 20,000 shares for $3.19 per share. The transaction valued at 63,800 led to the insider holds 51,000 shares of the business.
Zummo Jacqueline sold 21,224 shares of TARA for $96,145 on Mar 26 ’25. The Chf Scientific Operations Off now owns 98,861 shares after completing the transaction at $4.53 per share. On Mar 26 ’25, another insider, Zummo Jacqueline, who serves as the Officer of the company, bought 21,224 shares for $4.55 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TARA now has a Market Capitalization of 282404864 and an Enterprise Value of 74340864.
Stock Price History:
The Beta on a monthly basis for TARA is 1.44, which has changed by 0.023301005 over the last 52 weeks, in comparison to a change of 0.14402747 over the same period for the S&P500. Over the past 52 weeks, TARA has reached a high of $7.82, while it has fallen to a 52-week low of $2.77. The 50-Day Moving Average of the stock is -7.25%, while the 200-Day Moving Average is calculated to be 29.58%.
Shares Statistics:
The stock has traded on average 851.11K shares per day over the past 3-months and 1058740 shares per day over the last 10 days, according to various share statistics. A total of 51.63M shares are outstanding, with a floating share count of 46.17M. Insiders hold about 10.58% of the company’s shares, while institutions hold 46.06% stake in the company. Shares short for TARA as of 1764288000 were 2908827 with a Short Ratio of 3.42, compared to 1761868800 on 2825459. Therefore, it implies a Short% of Shares Outstanding of 2908827 and a Short% of Float of 7.7299999999999995.
Earnings Estimates
At present, 4.0 analysts are actively evaluating the performance of Protara Therapeutics Inc (TARA) in the stock market.The consensus estimate for the next quarter is -$0.36, with high estimates of -$0.33 and low estimates of -$0.4.
Analysts are recommending an EPS of between -$1.3 and -$1.42 for the fiscal current year, implying an average EPS of -$1.35. EPS for the following year is -$1.44, with 4.0 analysts recommending between -$1.3 and -$1.73.
